Central inhibition of nitric oxide synthesis increases blood pressure and heart rate in anesthetized rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 1, 1997, Pages 35-41

  Nurminen, M L ^a   Ylikorkala, A ^a   Vapaatalo, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

blood pressure; central nervous system; heart rate; L arginine; L NAME; nitric oxide

Indexed keywords

ATENOLOL; METHYLATROPINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; ENZYME INHIBITORS; HEART RATE; MALE; NG-NITROARGININE METHYL ESTER; RATS; RATS, WISTAR;

EID: 0031002351     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Moncada, S., Palmer, R.M.J., Higgs, E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43: 109-42.
2. Bredt, D.S., Hwang, P.M., Snyder, S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990, 347: 768-70.
3. Vincent, S.R., Kimura, H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992, 46: 755-84.
4. Palmer, R.M.J., Rees, D.D., Ashton, D.S., Moncada, S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988, 153: 1251-6.
5. Knowles, R.G., Palacios, M., Palmer, R.M.J., Moncada, S. Kinetic characteristics of nitric oxide synthase from rat brain. Biochem J 1990, 269: 207-10.
6. Rees, D.D., Palmer, R.M.J., Schulz, R., Hodson, H.F., Moncada, S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990, 101: 746-52.
7. Garthwaite, J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991, 14: 60-7.
8. Shibuki, K., Okada, D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991, 349: 326-8.
9. Calapai, G., Squadrito, F., Altavilla, D. et al. Evidence that nitric oxide modulates drinking behaviour. Neuropharmacology 1992, 31: 761-4.
10. G-Nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 1991, 102: 198-202.
11. Ling, L., Karius, D.R., Fiscus, R.R., Speck, D.F. Endogenous nitric oxide required for an integrative respiratory function in the cat brain. J Neurophysiol 1992, 68: 1910-2.
12. Kapas, L., Shibata, M., Kimura, M., Krueger,J.M. Inhibition of nitric oxide synthesis suppresses sleep in rabbits. Am J Physiol 1994, 266: R151-7.
13. Cabrera, C., Bohr, D. The role of nitric oxide in the central control of blood pressure. Biochem Biophys Res Commun 1995, 206: 77-81.
14. Tseng, C-J., Liu, H.-Y., Lin, H.-C., Ger, L.-P., Tung, C.-S., Yen, M.-H. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 1996, 27: 36-42.
15. ω-nitro-L-arginine. Eur J Pharmacol 1995, 287: 49-56.
16. Mollace, V., De Francesco, E.A., Nistico, G. Evidence that pharmacological manipulations of central L-arginine-NO pathway influence blood pressure and heart rate in rats. Neurosci Lett 1992, 137: 87-90.
17. Toda, N., Ayajiki, K., Okamura, T. Neural mechanism underlying basilar arterial constriction by intracisternal L-NNA in anesthetized dogs. Am J Physiol 1993, 265: H103-7.
18. G-nitro-L-arginine in anesthetized monkeys. Cardiovasc Res 1995, 38: 663-7.
19. Shapoval, L.N., Sagach, V.F., Pobegailo, L.S. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 1991, 132: 47-50.
20. Horn, T., Smith, P.M., McLaughlin, P.E. et al. Nitric oxide actions in paraventricular nucleus: Cardiovascular and neurochemical implications. Am J Physiol 1994, 266: R306-13.
21. D'Amico, M., Berrino, L., Filippelli, A., Maione, S., Rossi, F. Relation between L-arginine-nitric oxide pathway and endothelin-1 effects in periaqueductal gray area of rats. J Cardiovasc Pharmacol 1994, 24: 974-8.
22. G-Nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 1993, 72: 387-95.
23. Brezenoff, H.E., Giuliano, R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu Rev Pharmacol Toxicol 1982, 22: 341-81.